Qtron Investments LLC decreased its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 15.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,263 shares of the financial services provider’s stock after selling 2,574 shares during the quarter. Qtron Investments LLC’s holdings in MetLife were worth $1,168,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Retirement Wealth Solutions LLC bought a new stake in shares of MetLife in the 4th quarter worth approximately $32,000. Sierra Ocean LLC acquired a new stake in MetLife in the fourth quarter worth $32,000. Graney & King LLC acquired a new stake in MetLife in the fourth quarter worth $34,000. Values First Advisors Inc. bought a new stake in MetLife in the fourth quarter valued at $36,000. Finally, Golden State Wealth Management LLC bought a new position in shares of MetLife during the fourth quarter worth about $44,000. Institutional investors own 94.99% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have issued reports on MET. Piper Sandler boosted their target price on shares of MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research note on Wednesday, April 2nd. Wells Fargo & Company decreased their price objective on MetLife from $97.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday. Barclays cut their target price on MetLife from $95.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday. BMO Capital Markets initiated coverage on MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target on the stock. Finally, StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $92.46.
MetLife Stock Performance
MET opened at $71.25 on Friday. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The firm has a market cap of $48.54 billion, a PE ratio of 11.94, a P/E/G ratio of 0.65 and a beta of 0.89. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The business has a fifty day simple moving average of $80.32 and a 200-day simple moving average of $82.46.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Pros And Cons Of Monthly Dividend Stocks
- Delta Air Lines: This Phoenix Can Rise From the Ashes
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review — 04/07 – 04/11
- What is Short Interest? How to Use It
- JPMorgan is a Buy, if You Can Handle The Volatility
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.